HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Y C Mayur Selected Research

Acridones

10/2017Acridone-pyrimidine hybrids- design, synthesis, cytotoxicity studies in resistant and sensitive cancer cells and molecular docking studies.
3/2013Chemosensitizing acridones: in vitro calmodulin dependent cAMP phosphodiesterase inhibition, docking, pharmacophore modeling and 3D QSAR studies.
7/2011Cytotoxicity studies of some novel fluoro acridone derivatives against sensitive and resistant cancer cell lines and their mechanistic studies.
5/2009Design of new drug molecules to be used in reversing multidrug resistance in cancer cells.
9/2008Synthesis of 2-methyl N10-substituted acridones as selective inhibitors of multidrug resistance (MDR) associated protein in cancer cells.
1/2006Sensitization of multidrug resistant (MDR) cancer cells to vinblastine by novel acridones: correlation between anti-calmodulin activity and anti-MDR activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Y C Mayur Research Topics

Disease

12Neoplasms (Cancer)
01/2021 - 01/2006
2Leukemia
07/2011 - 11/2008
1Glioblastoma (Glioblastoma Multiforme)
01/2021
1Glioma (Gliomas)
01/2021
1Body Weight (Weight, Body)
01/2021
1Ulcer
01/2019
1Edema (Dropsy)
01/2019
1Epilepsy (Aura)
01/2019
1Inflammation (Inflammations)
01/2019
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2011
1Breast Neoplasms (Breast Cancer)
09/2008

Drug/Important Bio-Agent (IBA)

6acridoneIBA
01/2021 - 09/2008
6AcridonesIBA
10/2017 - 01/2006
5Calmodulin (Calcium-Dependent Activator Protein)IBA
03/2013 - 01/2006
3Doxorubicin (Adriamycin)FDA LinkGeneric
03/2013 - 11/2008
2Vincristine (Oncovin)FDA LinkGeneric
07/2011 - 11/2008
2C 1311IBA
07/2011 - 05/2009
2Member 1 Subfamily B ATP Binding Cassette TransporterIBA
05/2009 - 09/2008
1Drug CombinationsIBA
01/2021
1Temozolomide (Temodar)FDA LinkGeneric
01/2021
1Telomerase (Telomerase Reverse Transcriptase)IBA
01/2020
1Ibuprofen (Motrin)FDA LinkGeneric
01/2019
1Insulin (Novolin)FDA Link
01/2019
1SC 558IBA
01/2019
1Celecoxib (Celebrex)FDA Link
01/2019
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
01/2019
1pyrazoleIBA
01/2019
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2019
1CarrageenanIBA
01/2019
1pyrimidineIBA
10/2017
1Antineoplastic Agents (Antineoplastics)IBA
10/2017
1PyrimidinesIBA
10/2017
1AlkaloidsIBA
04/2017
13',5'-Cyclic-AMP Phosphodiesterases (3',5' Cyclic Nucleotide Phosphodiesterase)IBA
07/2011
1EnzymesIBA
07/2011
1AminesIBA
07/2011
1Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
05/2009
1Multidrug Resistance-Associated ProteinsIBA
05/2009
1ElacridarIBA
05/2009
1Cyclic AMP (AMP, Cyclic)IBA
05/2009
1Proteins (Proteins, Gene)FDA Link
09/2008
1CarbonIBA
09/2008
1Vinblastine (Vinblastine Sulfate)FDA Link
01/2006

Therapy/Procedure

2Therapeutics
01/2020 - 01/2019
1Oral Administration
01/2021
1Anesthesia
01/2019
1Drug Therapy (Chemotherapy)
01/2006